AIMT
Aimmune Therapeutics, Inc.
Director and 10% owner Patrick G Enright bought $499K of Aimmune Therapeutics, Inc.
Bought$498,976
$32.00Price
15,593Shares
What AIMT did for a copier
Prices for AIMT after this filing aren't in yet.
Patrick G Enright's record
8 other buys with 3 months of prices since 2020: on average −2.1% against the S&P 500, and 1 of 8 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Feb 22. Filed Mon, Feb 26, 11:22 AM ET, during the session. Not investment advice.